LCN2 and chronic kidney disease: In line with these findings, our results revealed that elevated LCN2 levels contributed to the ferroptosis of VSMCs in CKD-VC and that the downregulation of LCN2 expression reduced free iron and lipid oxidation, suggesting that the regulatory effect of LCN2 on CKD-VC occurs through the regulation of VSMCs ferroptosis.